Biocon Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOCON PHARMA, and what generic and branded alternatives to BIOCON PHARMA drugs are available?
BIOCON PHARMA has twelve approved drugs.
Summary for Biocon Pharma
US Patents: | 0 |
Tradenames: | 12 |
Ingredients: | 12 |
NDAs: | 12 |
Patent Litigation for Biocon Pharma: | See patent lawsuits for Biocon Pharma |
PTAB Cases with Biocon Pharma as petitioner: | See PTAB cases with Biocon Pharma as petitioner |
Drugs and US Patents for Biocon Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon Pharma | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 212297-002 | Nov 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209639-001 | Mar 13, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | SIMVASTATIN | simvastatin | TABLET;ORAL | 078034-005 | Dec 20, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 216436-003 | Nov 23, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 218070-002 | Feb 6, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.